Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Komal Sawlani, MD

Komal Sawlani, MD

  • Director, ALS Multidisciplinary Clinic, University Hospitals
  • Program Director, Neuromuscular Medicine, UH Cleveland Medical Center
  • Assistant Professor, CWRU School of Medicine
  • Specialty: Neurology, Neurology-Neuromuscular Medicine
  • Location:
    UH Suburban Health Center
    1611 S Green Rd
    South Euclid, OH 44121

Biography: Komal Sawlani, MD


  • Amyotrophic Lateral Sclerosis (ALS)
  • Carpal Tunnel Syndrome
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Electromyography (EMG)
  • Entrapment Neuropathies
  • Myasthenia Gravis (MG)
  • Myopathies
  • Nerve Conduction Studies (NCS)
  • Peripheral Neuropathies
  • Ulnar Neuropathies

Certifications & Memberships

  • Neuromuscular Medicine - American Board of Psychiatry and Neurology
  • Neurology - American Board of Psychiatry and Neurology


Fellowship | Neuromuscular Disease
Neuromuscular Disease - Brigham And Women's Hospital (2015 - 2016)

Residency | Neurology
Neurology - Uh Case Medical Center (2011 - 2015)

Medical Education
Indiana University School Of Medicine (2011)

Northwestern University (2007)

Research & Publications

Research Interests

Neuromuscular Disorders, Amyotrophic Lateral Sclerosis, EMG and Nerve conduction studies, Spinal muscular atrophy, Myasthenia Gravis

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Komal Sawlani did not disclose any Outside Relationships with Industry.